Pharmaceutical care management association
Encyclopedia
The Pharmaceutical Care Management Association (PCMA), is the American national trade association representing pharmacy benefit managers. According to the association's mission statement, PCMA advocates on behalf of its member companies, which claim to improve affordability of prescription drugs and quality of care through the use of tools such as electronic prescribing
(e-prescribing), promoting the increased use of generic drugs and mail-service pharmacies, and other innovative cost-saving tools.
PCMA has been involved in the debate in the United States Congress regarding the approval of a pathway for generic biosimilar
drugs or follow-on biologics. The Obama Administration has agreed with PCMA's position on biosimilars. The organization has run numerous ads urging Members of Congress for approval of a quick pathway for the Food and Drug Administration to approve biosimilars.
Electronic prescribing
Electronic prescribing or e-prescribing is the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of...
(e-prescribing), promoting the increased use of generic drugs and mail-service pharmacies, and other innovative cost-saving tools.
PCMA has been involved in the debate in the United States Congress regarding the approval of a pathway for generic biosimilar
Biosimilar
Biosimilars or follow-on biologics are terms used to describe officially-approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Biosimilars are also referred to as subsequent entry biologics ...
drugs or follow-on biologics. The Obama Administration has agreed with PCMA's position on biosimilars. The organization has run numerous ads urging Members of Congress for approval of a quick pathway for the Food and Drug Administration to approve biosimilars.